MOTS-c — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

MOTS-c

Also known as: Mitochondrial open reading frame of the 12S rRNA type-c, Mitochondrial ORF of the twelve S-c, MOTS-c peptide, Mitochondrial-derived peptide MOTS-c, Mitokine MOTS-c, 12S rRNA-c peptide

Mitochondrial-derived peptide (MDP) / Mitokine — 16-amino-acid peptide encoded within the 12S rRNA short open reading frame of the mitochondrial genome

Research chemicalLast updated: October 31, 2026Based on 50 peer-reviewed studies

What it is

MOTS-c is a peptide naturally produced by mitochondria during exercise and metabolic stress, studied for insulin resistance, obesity, aging, and cardiovascular protection. It works by activating pathways inside cells that improve how the body handles glucose and fat. Not FDA-approved; classified as a gray-market research compound; preclinical data is promising.

The scientific side

MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame (sORF) within the 12S rRNA gene of the mitochondrial genome. Under metabolic stress (e.g., glucose restriction, oxidative stress, exercise), MOTS-c translocates from mitochondria to the nucleus, where it regulates nuclear gene expression—including genes bearing antioxidant response elements (ARE)—and interacts with stress-responsive transcription factors such as NRF2/NFE2L2. Its primary described cellular mechanism involves inhibition of the folate cycle and de novo purine biosynthesis, leading to AMPK activation. MOTS-c activates AMPK, which in turn regulates downstream effectors including PGC-1α, HIF-1α, mTORC1, and PFKFB3, thereby modulating energy metabolism, mitochondrial biogenesis, glycolysis, oxidative stress responses, inflammation, autophagy, and apoptosis. MOTS-c also functions as a host defense peptide with direct antibacterial activity against pathogens including E. coli and MRSA, targeting bacterial membranes via its hydrophobic and cationic domains, and modulates innate immune cell differentiation. MOTS-c facilitates plasma membrane repair via interaction with TRIM72 and plasma lipids, interacts directly with intracellular proteins including Bcl-2, MYH9/actin complexes and LARS1, and acts on the KEAP1-NRF2 pathway. Circulating MOTS-c is detected in plasma; levels decline with age and are reduced in numerous disease states.

Class: Mitochondrial-derived peptide (MDP) / Mitokine — 16-amino-acid peptide encoded within the 12S rRNA short open reading frame of the mitochondrial genome

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification. One narrative review classifies MOTS-c among 'unapproved peptides' operating in a 'gray market' outside regulatory oversight, but does not state specific…

WADA

Not stated in reviewed literature — requires manual verification.

Health Canada

Not stated in reviewed literature — requires manual verification.